טוען...
Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis
Hydroxychloroquine (HCQ) is a commonly used drug for the treatment of systemic lupus erythematosus (SLE). Renal involvement is common in SLE. We present a 25-year-old woman with lupus nephritis on peritoneal dialysis whose lupus was quite silent for almost three years, and secondary to HCQ she devel...
שמור ב:
| הוצא לאור ב: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5911099/ https://ncbi.nlm.nih.gov/pubmed/29669768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-223639 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|